Eye Drops for Red Eyes: LUMIFY significantly reduces redness to help reveal your eyes' natural radiance. From the eye care experts at Bausch and Lomb, LUMIFY works in 1 minute and lasts up to 8 ...

Bausch & Lomb (NYSE:BLCO) fell 5.6% in premarket trading ... and will not result in a transaction at this time." The eye care company said full separation remains the goal, according to the ...

There are also eye drops that can help with dry eyes caused by wearing contact ... we highly recommend the Sensitive Eyes Contact Lens Solution by Bausch + Lomb for anyone with sensitive eyes ...

US FDA warns consumers over copycats of Bausch + Lomb eye drops January 31 ... a year after it completes its $1.75 billion deal for dry eye drug Xiidra, recently rehired chief executive Brent ...

Bausch & Lomb Corp.’s stock soared 10% early ... Growth was driven by higher sales of Lumify eye drops, Eye Vitamins and Dry Eye Portfolio in the consumer eye-care business and higher sales ...

Bausch + Lomb's product portfolio, particularly its prescription Dry Eye Disease (DED) offerings, has been a focal point for investors and analysts. The company's newest DED drug, Miebo, has shown ...

Bausch Health failed to agree a deal to sell its Bausch + Lomb eyecare subsidiary but remains focused on a separation. Bausch + Lomb said Thursday talks held with potential buyers won't result in a ...

Bausch & Lomb (NYSE:BLCO) fell 5.6% in premarket trading after ending a sales process without finding a buyer. “Taking Bausch + Lomb private with a third-party buyer was one of several options being ...